Norges Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $181M | Buy |
+5,034,369
| New | +$181M | 0.02% | 506 |
|
|
2025
Q1 | – | Sell |
-4,880,346
| Closed | -$124M | – | 1336 |
|
|
2024
Q4 | $124M | Buy |
+4,880,346
| New | +$124M | 0.02% | 600 |
|
|
2024
Q3 | – | Sell |
-4,809,343
| Closed | -$127M | – | 1399 |
|
|
2024
Q2 | $127M | Buy |
4,809,343
+309,282
| +7% | +$8.16M | 0.02% | 560 |
|
|
2024
Q1 | $137M | Buy |
4,500,061
+237,325
| +6% | +$7.21M | 0.02% | 554 |
|
|
2023
Q4 | $120M | Buy |
4,262,736
+126,399
| +3% | +$3.55M | 0.02% | 543 |
|
|
2023
Q3 | $112M | Buy |
4,136,337
+39,186
| +1% | +$1.06M | 0.02% | 535 |
|
|
2023
Q2 | $126M | Sell |
4,097,151
-270,557
| -6% | -$8.32M | 0.02% | 514 |
|
|
2023
Q1 | $157M | Buy |
4,367,708
+551,351
| +14% | +$19.9M | 0.03% | 433 |
|
|
2022
Q4 | $151M | Buy |
3,816,357
+318,753
| +9% | +$12.6M | 0.04% | 426 |
|
|
2022
Q3 | $141M | Buy |
3,497,604
+104,107
| +3% | +$4.18M | 0.04% | 411 |
|
|
2022
Q2 | $143M | Buy |
3,393,497
+322,101
| +10% | +$13.5M | 0.04% | 417 |
|
|
2022
Q1 | $120M | Buy |
3,071,396
+111,156
| +4% | +$4.33M | 0.03% | 524 |
|
|
2021
Q4 | $118M | Buy |
2,960,240
+99,510
| +3% | +$3.97M | 0.02% | 549 |
|
|
2021
Q3 | $103M | Buy |
2,860,730
+65,778
| +2% | +$2.38M | 0.02% | 599 |
|
|
2021
Q2 | $115M | Buy |
2,794,952
+31,815
| +1% | +$1.3M | 0.02% | 584 |
|
|
2021
Q1 | $121M | Buy |
2,763,137
+1,740,566
| +170% | +$75.9M | 0.03% | 569 |
|
|
2020
Q4 | $51.2M | Buy |
1,022,571
+300,208
| +42% | +$15M | 0.01% | 956 |
|
|
2020
Q3 | $30.4M | Sell |
722,363
-1,580,145
| -69% | -$66.5M | 0.01% | 1156 |
|
|
2020
Q2 | $112M | Buy |
+2,302,508
| New | +$112M | 0.03% | 464 |
|